I Need Something Stronger Before My Exams

Home I Need Something Stronger Before My Exams

No audio available for this specialty.

CANDIDATE’S NOTES (Video Consultation)

BRENNAN, Toby – 17, male

Reason for contact (reception): “Hay fever is really bad, wants something stronger before his exams.”

Problem list: Atopic eczema – aged 4 to 7, resolved.

Allergies: Nil known.

(Booked as a routine video appointment.)

ROLE PLAYER BRIEF

The card

  • Who you are: Toby Brennan, 17, final school year, revising at home, weekend football, three weeks from your first A-level examination.
  • Your opening words, verbatim: “It’s my hay fever, basically. It’s worse than it’s ever been and my exams start in three weeks – I just need something stronger. Mum got me some tablets and they did nothing.”
  • What you want: the strongest tablets available, without going anywhere.
  • Not volunteering: the two of your mother’s Piriton at bedtime; that you have not had a clear day in seven weeks; the cat on your bed.
  • How you feel: breezy, faintly dismissive – quieter and more honest once someone counts what it is costing you.

Volunteer once

Early, unasked:

  • “I read the same page four times last night and I still couldn’t tell you what was on it.”
  • “Mum got me some tablets and they did nothing.”

If asked

If the doctor asks about… Say…
how long, or how bad, in general terms “On and off since it warmed up, I suppose. Some days are worse than others.” (True. Add nothing.)
a number – days out of seven, weeks, nights Accurately: “None. All seven.” / “Seven weeks, near enough.” / “Five nights. Maybe six.”
the symptoms themselves Sneezing in runs; nose streaming clear or blocked solid; itchy nose and palate; eyes red, itchy and watering, and you rub them; mouth-breathing and snoring at night; dry night cough; postnasal dribble.
triggers, and the rest of the year “Outdoors – worst first thing and early evening. Streaming for hours after football three days ago. Better with the windows shut.” Then: “I’m always a bit bunged up first thing, all year. Worse if the cat’s been on the bed.”
pets “There’s Pickle – he’s a cat, he sleeps on my bed.” (You can tilt the camera and show him.)
medication, asked directly (“are you on anything?”) “No, nothing. Just the ones Mum bought that didn’t work.”
medication, asked after normalising it (the family medicine drawer; what you actually take rather than what you were given) Pause. “…Mum’s Piriton. Two of them, at bedtime. Most nights for about ten days. It’s the only thing that gets me to sleep.” Pick the packet off the desk and hold it up.
the tablets your mother bought, and whether she knows about the Piriton “Loratadine. Ten milligrams. Four days, did nothing, so I stopped. That was a fortnight back.” / “She doesn’t know. She’d go mad.”
your chest No wheeze, no breathlessness, no tightness – you ran the whole match three days ago. Just the dry cough at night.
your nose – sides, blood, pain, smell, vision Both sides the same. No blood, no nosebleeds, no pain across your face or nose, smell unchanged, vision fine.
eczema and family “Had it as a kid, arms and behind my knees – went years ago.” / “Mum’s had hay fever for years, that’s whose Piriton it is.”
who is at home, and what they say “Mum’s downstairs. Niamh – my sister, she’s fourteen – is at her mate’s.” / “Mum says it’s just hay fever and I should get on with it.” / “Niamh says I snore now, she can hear me through the wall.”
driving, and drink “I’m learning – three lessons in, one booked in four days.” / “Odd can at a mate’s, once a month maybe. Nothing for weeks, I’m revising.”
what you think it is, and steroids (Ideas) “It’s just hay fever. It’s been a hot one this year, that’s all.” / “Isn’t that the stuff that bulks you up? Mum’d not be keen.”
what worries you (open question only, after a pause) (Concerns) “That I’m going to sit down in that hall and not be able to think. My offer’s conditional.”
home equipment Bathroom scales only – no thermometer, no blood pressure monitor, no peak flow meter.
coming in to the surgery “Do I have to come in? I’ve got three weeks and I’m behind as it is – is there not something you can just send to the chemist?”

IDEAS
It’s just hay fever, and it’s been a hot summer — nothing more than that. Underneath: a stronger tablet is simply what hay fever gets; that’s what everyone is given. Steroids are “the stuff that bulks you up”, and his mum wouldn’t be keen on them.

CONCERNS
That he’ll sit down in the exam hall and not be able to think, with a conditional university offer riding on the grades. Gated — it comes out only on an open, unhurried worry question with a pause left for the answer, or after the doctor acknowledges what the lost sleep and lost revision are costing him. A closed “any worries?” will not release it.

EXPECTATIONS
The strongest tablets available, today, without having to attend: “Is there not something you can just send to the chemist?”

 

Your questions

Ask both, in these words, unless already fully answered:

  • “Why can’t you just give me the strongest tablets? Everyone gets tablets for hay fever.”
  • “Will it have kicked in before my first exam? That’s three weeks.”

 

 

SIMULATION & DIRECTION NOTES (for the AI patient; role-players may skim)

Voice and manner (the microphone test).

Normal, consistent volume throughout. You start fast and flat, sentences running together, ending on a short exhale as if this were a formality. The voice is nasal and muffled, as though through a blocked nose; you sniff and clear your throat every couple of minutes. When the nights are counted the pace drops: leave a gap before “None. All seven”, and let the answers shorten. Before you say what frightens you there is an audible pause, and the voice thins on “conditional”. Told off, you go flat and monosyllabic.

Speaking register and information release.

Plain seventeen-year-old English. No medical words, no diagnosis beyond “hay fever”, never a tidy chronological history. Your first answer to anything broad is partial and minimising; detail comes only on the specific follow-up. Give one or two things, then wait. A general question about duration or severity gets the honest, non-discriminating reply in the table – it is true, and you conceal nothing; you simply do not think in weeks and nights until asked to. A question asking for a number gets an accurate number every time.

Gated clinical discriminator.

The fact: the counted answers and the year-round background, both in the IF ASKED table.

The decoy: the vague question (“Has it been going on long?”, “Is it bad?”) meets “On and off since it warmed up, I suppose. Some days are worse than others.” He answers exactly the question asked; the question is inadequate.

The unlock: a request for counts, in any wording – no keyword required.

Confirmation: never in the notes, never volunteered, lay wording only.

Cross-wiring: Part D quotes the decoy in the Data Gathering negatives and the counted characterisation in the positives and ladder; Part E demonstrates the unlock at the second hinge.

Hidden agenda and reveal rule.

The hidden content is shame: the Piriton is not his, and two is more than one. Reveal only when the behaviour is normalised before the question – anything of the shape “a lot of people end up going through the family medicine drawer”, or asking what he is actually taking rather than what he was given. A direct or accusatory question gets the literally true refusal in the table, and the packet stays on the desk. Disapproval closes him for the rest of the run. The examination fear is separate: released by an open worry question or by acknowledgement of the lost revision, never by a closed “any worries?”.

Non-speaking presence (locked).

Marianne (mother) is downstairs throughout; Niamh (sister, 14) is out. Neither enters the room, is heard, or appears on camera – one person is in frame the whole time, and there is no entrance and no exit: if either moves, the run has drifted. Their words reach the candidate only as Toby reporting them, attributed, in these locked lines: “Mum says it’s just hay fever and I should get on with it.” / “Mum got me the loratadine – she said give it a week, and I gave it four days.” / “She doesn’t know. She’d go mad.” / “Niamh says I snore now, she can hear me through the wall.” / “Mum’d not be keen on steroids.” There is no presence gate: nothing is withheld while they are in the house, because neither is in the room.

ICE (Ideas, Concerns and Expectations).

Ideas and Concerns are the table rows of those names; underneath the idea is the belief that a stronger tablet is what hay fever gets.

Expectations – the strongest tablets available, today, without attending.

Cues (each offered once per run; wording flexible).

The two VOLUNTEER ONCE lines, an audible pause and shorter answers when the examinations come up, and “it’s only hay fever”.

Good versus poor consultation.

Listened to and asked for numbers, he warms up, stops minimising and negotiates – about the cat, and about stopping the Piriton. Rushed, checklisted or told off, he answers in three words and agrees without meaning it. Handed a plan with no reason, he says he will “see how it goes”.

Findings on request (remote constraints apply).

Visible on video: darkened shadows under both lower lids; a horizontal crease across the bridge of the nose; mouth-breathing; both eyes red and watering; eye-rubbing and the heel of the hand pushed up under the nose; a bedroom desk, revision cards, two medicine packets by the laptop; Pickle if he tilts the camera. He looks well and alert.

Audible: nasal, muffled speech, sniffing, throat-clearing, an occasional dry cough; no breathlessness or wheeze.

Home-measured: bathroom scales only.

Cannot provide: anything needing hands or instruments – “I can’t really see that myself.”

Red flags – state of play.

All ABSENT, as the nose and chest rows of the IF ASKED table give them: no unilateral symptoms, no blood-stained or discoloured discharge, no nosebleeds, no nasal or facial pain, no loss of smell, no visual disturbance, no fever, no wheeze, breathlessness, tightness or exercise limitation. What is PRESENT is the symptom row.

Face-to-face response – classification OVER-CAUTIOUS.

He does not need examining: no red flags, the diagnosis is made from the history, and the appearance inside the nose is often normal in this condition anyway. His reluctance is genuine and the obstacle real.

Push-back, verbatim: “Do I have to come in? I’ve got three weeks and I’m behind as it is – is there not something you can just send to the chemist?”

Agree-trigger: none exists in this case. Persisted with, he stays reluctant and asks “What would you be looking for?”; pressed further he attends grudgingly, half the consultation gone. Conclude safely on video with a safety-net.

Items written in the patient’s own words.

None – every item on this record is named.

Actor latitude.

LOCKED: every clinical fact above, including the timeline (seven of seven days, seven weeks, five broken nights, ten days of Piriton, four days of loratadine stopped a fortnight ago, football three days ago, driving lesson in four days, first examination in three weeks) and the present-and-absent red-flag list; the hidden agenda and its normalisation-only reveal rule; the counted answers and the vague reply preceding them; the ICE positions; the OVER-CAUTIOUS classification and the absence of any agree-trigger; the two patient questions; the verbatim opening line; the cue drops; the good-versus-poor policy; and the non-speaking presence mechanics as written.

FLEXIBLE: the wording of push-back and ordinary answers, emotional intensity within range, the order of secondary detail, and small talk in character.

Tone: a seventeen-year-old who thinks he is wasting the doctor’s time, not someone reading a script.

PART A – MARKING GUIDE

The SCA is marked holistically by a trained examiner against the standard of a newly qualified, independent GP. The indicators and anchors below are training aids that approximate that judgement – not a checklist where each item earns a mark, and timings are pacing guides, not thresholds.

Use the indicators as evidence, the Pass/Fail boundary for the judgement, and the moment table for feedback.

TIER 1

Data Gathering & Diagnosis

Positives Negatives
•   Opens with one open question; lets the account run.

•   Picks up “the same page four times” and asks its cost.

•   Counts days, weeks and broken nights – seven, seven, five.

•   Elicits the year-round blockage and the cat on the bed.

•   Normalises before asking what he is actually taking.

•   Screens the chest; confirms the eczema entry aloud.

 •   Accepts “on and off since it warmed up… some days are worse than others”.

•   Takes “no, nothing” at face value; never finds the Piriton.

•   Labels it hay fever; never separates intermittent from persistent.

•   Rattles the red-flag screen, or omits the urgent four.

CASE ESSENTIALS

Working diagnosis: allergic rhinitis, persistent and moderate-to-severe, pollen-driven on a year-round animal-dander background.
Must exclude (the required screen): unilateral symptoms, blood-stained discharge, recurrent nosebleeds or nasal pain – any one takes the urgent two-week-wait ear, nose and throat (ENT) route; discoloured discharge, loss of smell or visual disturbance instead mean consider an alternative diagnosis on its own merits. All absent here, and a passing candidate says so aloud.
Must-not-miss: an adjective is not a classification – and Part F carries the questions that separate infective and irritant rhinitis from this.

Calibration

Clear Pass – everything at Pass, plus the discriminator below, done in the room.

Pass – Opens with one open question and lets the account run; picks up the revision cue and follows it. Asks for numbers and gets seven days of seven, seven weeks and five broken nights, so the disease is classified rather than labelled. Screens red flags and the chest; finds the Piriton after normalising.

– PASS STANDARD –

Fail – Takes “hay fever” at face value and heads for treatment. “On and off since it warmed up” is written down and never converted into days, weeks or nights, so nothing separates a bad fortnight from seven weeks. Red-flag screen partial; the Piriton never surfaces.

Clear Fail – A closed checklist from minute one: no timeline, no severity, no red flags.

 

Clinical Management & Medical Complexity

Positives Negatives
•   Names the counted pattern as the reason for a spray.

•   Prescribes mometasone 50 micrograms per spray, two sprays each nostril, once daily.

•   Counsels onset 6–8 hours, full effect about two weeks.

•   Teaches technique: look down, opposite hand outwards, do not sniff.

•   Stops the chlorphenamine, naming the driving lesson and the hall.

•   Safety-nets visual change, mood change, nosebleeds; reviews at two weeks.

 •   Issues the stronger tablet he asked for.

•   Prescribes the spray with no onset counselling.

•   Adds an oral antihistamine on top for no added benefit.

•   Insists on attendance with no clinical reason.

SAFE ALTERNATIVE APPROACHES (source-defensible routes that must not be failed; judge how the route is applied, explained, negotiated and safety-netted)

  • Fluticasone propionate or fluticasone furoate instead of mometasone – on device, cost or availability; all three have the lowest systemic absorption and comparable efficacy.
  • Intranasal corticosteroid plus intranasal antihistamine from the outset – a named first-line option at this severity, more effective than the corticosteroid alone.
  • Advising over-the-counter purchase rather than prescribing – defensible where policy restricts prescribing for seasonal disease; prescribing is equally defensible here.

CASE ESSENTIALS

Must-not-miss: a borrowed first-generation antihistamine, two at a time, in a learner driver three weeks from examinations.
Investigations: none – the treatment response is the test.
Face-to-face: OVER-CAUTIOUS. Positive: concludes on video with a red-flag safety-net. Negative: insists on attendance with no clinical reason, across “Do I have to come in? I’ve got three weeks and I’m behind as it is.”

Calibration

Clear Pass – everything at Pass, plus the discriminator below, done in the room.

Pass – Names the pattern as the reason for a spray; prescribes mometasone two sprays into each nostril once daily and teaches technique. Counsels the two-week clock, so the four-day abandonment that ended the loratadine does not repeat. Stops the Piriton, safety-nets, reviews at two weeks.

– PASS STANDARD –

Fail – Arrives at a nasal spray but hands it over as a prescription. Onset and the two-week maximal effect are never said, so nothing protects the plan from being abandoned in four days. The chlorphenamine is left running beside the driving lessons.

Clear Fail – Issues a stronger tablet on request, or a spray with no dose and no safety-net.

 

Relating to Others

Positives Negatives
•   Lets “it’s only hay fever” stand and explores the cost instead.

•   Reflects his words – “the same page four times”.

•   Normalises first; meets the answer without judgement.

•   Answers “why not tablets?” as a trade-off, with a next step.

•   Checks the technique back in a form he could get wrong.

 •   Corrects the minimising instead of exploring what it costs.

•   Reacts with disapproval to the Piriton; he closes down.

•   Refuses flatly – “you don’t need those” – with no alternative.

Calibration

Clear Pass – everything at Pass, plus the discriminator below, done in the room.

Pass – Lets the minimising stand and explores the cost instead. Normalises the family medicine drawer before asking, so the Piriton comes out and is met without judgement. Answers the tablets question as a trade-off; checks the technique back.

– PASS STANDARD –

Fail – Polite and efficient, but the minimising is corrected rather than explored. Nothing is normalised before the medication question, so the packet stays on the desk and the examination fear is never named. The plan is delivered, not negotiated.

Clear Fail – Tells him off about his mother’s tablets, talks over the cues, leaves a prescription and no reason.

Clear Pass discriminator

Clear Pass candidates get the numbers before they go near a treatment, say the pattern back to Toby – seven days of seven, seven weeks, five broken nights – as the reason a spray beats a tablet, and hang the two-week clock on his three-week countdown. Pass candidates reach the same prescription and explain it well; Clear Pass candidates leave Toby able to say why it is a spray, which is what stops him abandoning it in four days as he abandoned the loratadine.

Moment calibration table

Moment Failing version Passing version Clear Pass version
Opening, and the record Reads the booking note aloud; interrupts at once Open question, account runs, eczema checked aloud Turns “the same page four times” into the next question
Counting the disease Accepts “on and off since it warmed up” and moves on Asks for days, weeks and nights; gets seven, seven, five Says the counted pattern back before naming a treatment
The medication history “Any medication?” – takes “no, nothing” Normalises first; the Piriton and the two-at-a-time emerge Receives it as evidence of the nights
Spray rather than tablets Prescribes what he asked for, or a spray unexplained Explains blockage versus itch; names the next step Sets the two-week clock against his three weeks
Closing on video Insists on attendance; no safety-net Remote close; visual, mood, nosebleed net; review two weeks Has him say the technique back

 

SIMULATION MARKING & CLINICAL REFERENCE (for the AI grader; markers may skim)

Face-to-face working.

The diagnosis comes from the history, and the appearance inside the nose is often normal here, so inspection changes neither drug, dose nor safety-net. A brief, reasoned offer dropped when he pushes back is not a fail; insisting across his obstacle is.

Investigations reasoning.

None indicated: with a typical history, the trial of first-line treatment is itself the first investigation. Skin-prick or serum specific immunoglobulin E (IgE) testing is for diagnostic doubt, failure to respond, or avoidance measures needing the allergen confirmed; recent antihistamines suppress skin-prick results, and up to 15% of positive tests are not clinically relevant.

Extended safe-alternative reasoning.

The three routes are equivalent starting points, not a ranking; the intranasal-antihistamine combination is more effective but adds a second device to a boy who abandoned one treatment in four days. An oral antihistamine alone is not a safe alternative: it under-treats persistent, moderate-to-severe disease.

Evidence map

Behaviour Rests on Released by Credit Do not credit
Counts days, weeks, nights 7 of 7; 7 weeks; 5 broken nights A question asking a number Any request for a count Accepting the vague reply
Finds the chlorphenamine Two 4 mg tablets nocte, ten days Only after normalising Normalising, then an open question A direct question, truthfully refused
Classifies before treating Persistent ≥4 days a week and ≥4 weeks; moderate-to-severe = sleep or activities affected DG3 Pattern given as the reason Diagnosis, then a drug
Drug, dose, onset Mometasone 50 micrograms per actuation, two into each nostril once daily from age 12; onset 6–8 hours, maximal about two weeks Candidate’s Dose, route, frequency, both time figures A spray with no dose; “give it time”
Technique and ceiling Look down; opposite hand outwards; do not sniff; do not exceed the dose or switch preparation Candidate’s Three technique elements plus a ceiling point “The leaflet explains it”
Stops the chlorphenamine Not recommended; sedation and cognitive impairment worsen driving and examination performance; single dose 4 mg DG5 Stopping it and a usable reason Stopping it as a rule
Net, review, remote close Visual disturbance; mood change; nosebleeds; review 2–4 weeks Candidate’s Two triggers, an interval, a remote close “Come back if it’s no better”
Non-judgemental handling He goes flat if told off DG5 A warm, purposeful first response Disapproval or a lecture
The two locked questions Questions 1 and 2 Asked every run if unanswered Tablets as a trade-off; timing with both figures A bare refusal; no number

 

CLINICAL REFERENCE

Prescription detail table

Drug Dose, formulation, route Frequency / duration How to take Key warnings & cautions for THIS patient
Mometasone furoate 50 micrograms per actuation aqueous nasal spray, intranasal. Two actuations into each nostril = 100 micrograms per nostril, 200 micrograms total daily Once daily, every day throughout the exposure period, not as needed. Reduce to one actuation into each nostril (100 micrograms daily) once controlled. Maximum four actuations into each nostril once daily (400 micrograms daily). Review at two weeks. Restart about two weeks before the next exposure period; several weeks ahead if the timing is uncertain Shake the container; look down; opposite hand to the nostril so the nozzle aims at the outside wall; squeeze once or twice while breathing in gently; do not sniff. Do not exceed the prescribed dose – no evidence of additional benefit. Do not switch preparation; efficacy is comparable across them. Onset 6–8 hours; maximal effect not until about two weeks Checked against this record: no recent nasal surgery, no untreated nasal infection, no pulmonary tuberculosis, no immunosuppression, no transfer from systemic corticosteroid, no predisposition to raised ocular pressure or glaucoma, no corticosteroid by any other route, no interacting enzyme inhibitor, no recorded allergy. MHRA (Medicines and Healthcare products Regulatory Agency): report blurred vision or other visual disturbance during corticosteroid treatment, and consider ophthalmology referral to establish the cause; psychological and behavioural effects – sleep disorders, anxiety, low mood, aggression – are recognised with intranasal corticosteroids and should be reported. Common local effects: epistaxis, nasal ulceration, altered smell and taste, throat irritation. Chosen over other intranasal corticosteroids because mometasone, fluticasone propionate and fluticasone furoate carry the lowest systemic absorption – verdict: any of the three is equally acceptable
Sodium cromoglicate (advised for purchase at the pharmacy; prescribing it is equally acceptable) 2% w/v eye drops, topical ocular. One or two drops into each eye Four times a day, regularly rather than as needed. At least two weeks of routine use before full prophylactic benefit. Discard the bottle four weeks after opening Start today so the loading period runs alongside the spray’s two weeks. Do not rub the eyes – rubbing worsens them. Cold compresses and ocular lubricants may be used alongside No contact lenses in use, so the avoid-lenses rule does not bite. Transient blurring may follow instillation: no driving or other skilled task until vision is clear – relevant to his lessons. An antihistamine eye drop is an equally acceptable alternative and acts faster, over a shorter licensed treatment period

Not appropriate in this case:

•   Chlorphenamine, or any first-generation sedating antihistamine – first-generation agents are not recommended; the sedation and cognitive impairment worsen driving and examination performance that rhinitis is already impairing, and he has a lesson in four days and examinations in three weeks. Two 4 mg tablets at once exceed the stated 4 mg single dose, though they remain below the 24 mg daily maximum for his age. Alcohol enhances the effect, and it should not be combined with other antihistamine-containing products.

•   An oral antihistamine added to the intranasal corticosteroid – no more effective than the corticosteroid alone: a second thing to remember for no additional benefit. An intranasal antihistamine alongside is a different matter and does add to it.

Investigation detail: no test indicated – see the reasoning above. Nothing is awaited, so there is no results-and-recall pathway; the interim net is the treatment-response net below.

Safety-net set (all triggers):

•   Treatment response – video review at two weeks; sooner if there is no change at all.

•   Intranasal corticosteroid – stop the spray and contact the surgery the same day for blurred vision or any change in vision; contact if he or the family notice a change in mood, temper or sleep; contact for repeated nosebleeds or persistent nasal soreness.

•   Red flags – symptoms becoming one-sided, blood-stained discharge, recurrent nosebleeds, or nasal or facial pain: be seen rather than wait.

PART B – MODEL CONSULTATION & MANAGEMENT

B0. History hinges

0:00 GP: “Hello Toby – thanks for joining me. What would you like to start with today?”

Toby: “It’s my hay fever, basically. It’s worse than it’s ever been and my exams start in three weeks – I just need something stronger. Mum got me some tablets and they did nothing.”

GP: (says nothing; lets the pause sit)

Toby: “I’m sneezing all day, my nose is either running or blocked solid, my eyes are killing me. I read the same page four times last night and I still couldn’t tell you what was on it.”

0:55 GP: “The same page four times – with three weeks to go, that’s the part I’d most want to fix. What are the nights doing?”

Toby: “I can’t breathe through my nose lying down. I’m awake at two, three in the morning with my mouth like sandpaper.”

1:40 GP: “I’m going to ask you for some numbers, because how often this happens is what decides which treatment is right for you. Out of the last seven days, how many were you actually free of it?”

Toby: “None. All seven.”

GP: “And how long has it been every day like this – not on and off, but like this?”

Toby: “Seven weeks, near enough.”

GP: “Of the last seven nights, how many did it wake you or stop you dropping off?”

Toby: “Five. Maybe six.”

3:10 GP: “That’s exactly what I needed. Two more areas, then we’ll talk about what to do – some checking questions about your nose and your chest, then what you’ve been taking.” (runs the red-flag and chest screen) “So: both sides the same, no blood, no nosebleeds, no pain across your face, smell and vision unchanged, and you ran the whole match three days ago. All reassuring – those are the things that would have sent you elsewhere today, and not one of them is there. I can see you had eczema as a small boy – anyone else in the family with hay fever?”

Toby: “Mum’s had it for years.”

4:50 GP: “Now, one I ask everyone. A lot of people end up going through whatever’s in the family medicine drawer when nothing’s working. What have you actually been taking – not what you were given?”

Toby: (pause) “…Mum’s Piriton. Two of them, at bedtime. Most nights for about ten days. It’s the only thing that gets me to sleep.” (picks the packet off the desk and holds it to the camera)

GP: “Thank you – that’s useful, and it tells me more about the nights than anything else you’ve said.”

6:10 GP: “Let me check I have this right. Seven days of seven for seven weeks, five broken nights in the last week. Worst outdoors and after football, better with the windows shut – and bunged up every morning all year, worse when Pickle’s been on the bed. Four days of loratadine that did nothing, ten days of your mum’s Piriton. Have I missed anything?”

Toby: “No, that’s it.”

B1. Explain the condition

6:45 GP: “So this is hay fever – allergic rhinitis. But what matters isn’t the label, it’s the pattern. It’s there most days, it’s run seven weeks rather than flaring for a day here and there, and it’s taking your sleep and your revision. That makes it the persistent, more troublesome kind – and that’s what changes the treatment.”

GP: “And it explains the loratadine. Tablets are aimed at the sneezing and the itch; they do very little for a blocked nose – and blocked is your worst symptom, the one keeping you awake. A steroid nasal spray settles the swelling in the lining, so it’s the one that unblocks you.”

GP: “What do you already know about steroid nasal sprays?”

Toby: “Isn’t that the stuff that bulks you up? Mum’d not be keen.”

GP: “A different sort of steroid altogether, and it’s a common worry. This is a very small dose that works on the lining of your nose. At the dose you’ll be on, very little gets into the rest of your body – which is why I’m choosing this one.”

B2. Respond to ICE

7:45 GP: “You came wanting the strongest tablets – that’s what people get handed for hay fever, so it’s a fair place to start. But I don’t think tablets are what’s holding you back. What’s worrying you about the next three weeks?”

Toby: (pause) “That I’m going to sit down in that hall and not be able to think. My offer’s conditional.”

GP: “Then that’s what we’re treating. Sleeping through the night and walking into that hall with a clear head – that’s what I want out of this too, not just fewer sneezes.”

B3. Management plan

8:20 GP: “The spray is mometasone. Two sprays into each nostril, once a day, every single day – not only on the bad days. Do it when you brush your teeth and you won’t have to remember it.”

GP: “Here’s the part that caught you out last time. You’ll notice something within about six to eight hours of the first dose, but it isn’t working at full strength until you’ve been on it about two weeks. Four days and giving up is what happened with the tablets, and it would happen again. Your first exam is three weeks off – two of those weeks are what the spray needs, which leaves you a week in hand.”

GP: “Technique matters more than people expect. Shake it. Look down at the floor. Right hand for your left nostril, so the nozzle points out towards your cheek rather than at the middle. Squeeze while you breathe in gently – and don’t sniff hard, or it goes down your throat and does nothing.”

GP: “Tell me back – tomorrow morning, what are you doing with your head, and what are you not doing?”

Toby: “Look down. Opposite hand. And don’t sniff it up.”

GP: “That’s it exactly. Two last things: don’t go above two sprays each side, because more doesn’t work better; and if it feels slow, don’t swap brands – they all work about as well as each other, and swapping just restarts the two weeks.”

9:40 GP: “The Piriton needs to stop, and not only because it isn’t yours. It’s an older antihistamine, and the drowsiness is why it feels like it’s working. That same drowsiness dulls concentration and slows reactions – and you’ve a driving lesson in four days and an exam hall in three weeks. Two at once is also more than a single dose is meant to be.”

Toby: “So what do I do tonight?”

GP: “Stop it tonight, start the spray in the morning. Your nose won’t change overnight – that’s expected, not the spray failing.”

GP: “For your eyes, ask the pharmacist for sodium cromoglicate allergy drops. One or two drops in each eye, four times a day. Same story as the spray – about two weeks of regular use before they’re at their best, so start today. Try to stop rubbing them; rubbing makes them worse. And if they blur for a minute afterwards, wait until your vision’s clear before you drive.”

10:20 GP: “A few things that cost nothing. After football, shower and wash your hair before you sit down to revise – the pollen’s in your hair. Bedroom window shut first thing and early evening, when the count is highest, and washing dried indoors on the bad days. Wraparound sunglasses on the walk to the hall.”

GP: “And one worth testing at home, because I can’t tell from here. Keep Pickle out of your bedroom for the next fortnight and see whether those first-thing mornings change. If they do, he’s part of it – and the fuller advice with a cat you react to is that ideally he isn’t in the house at all, or he’s kept to one room, and he and his bedding get washed regularly. Is starting with the bedroom a problem?”

Toby: “He’ll cry outside the door… Niamh’ll have him in with her, I reckon.”

GP: “That works.”

11:00 Toby: “Why can’t you just give me the strongest tablets? Everyone gets tablets for hay fever.”

GP: “Because for what you’ve described, the strongest tablet isn’t the strongest treatment. Tablets are good at itch and sneezing and poor at congestion – you’ve already had four days of exactly that. And a tablet on top of the spray doesn’t beat the spray alone, so it’s a second thing to remember for no extra benefit. It isn’t that you can’t have more; it’s that the spray comes first. If it isn’t enough in two weeks, the next step is an antihistamine spray alongside it – and that one does add to it.”

Toby: “And will it have kicked in before my first exam? That’s three weeks.”

GP: “Yes, if you start tomorrow. Something within six to eight hours, full effect at about two weeks, exam at three.”

B4. Ideal close

11:30 GP: “So: mometasone, two sprays each nostril every morning from tomorrow; drops from the pharmacy four times a day; Piriton stops tonight; shower after football; Pickle sleeps with Niamh. Another video appointment in two weeks, before the exams start, so there’s time to change things. Ring sooner if it’s no better at all.”

GP: “Three things would make me want to hear from you before then. If your vision blurs or changes at all on the spray, stop it and ring us the same day. If you or anyone at home notices your mood or temper changing, ring us. And if your nose bleeds repeatedly or stays sore, ring us. Separately – if it ever becomes one-sided, or there’s blood in what’s coming out, the two I checked earlier and you didn’t have, I want to see you rather than wait it out.”

GP: “I’ll send you the Allergy UK hay fever factsheet and the NHS hay fever page, so the avoidance advice isn’t yours to remember. What’s still unclear?”

Toby: “Nothing. Two weeks. Don’t sniff it.”

 

PART C – GOLDEN HISTORY-TAKING QUESTIONS

  • “What would you like to start with today?”
  • “You said you read the same page four times – what is that doing to your revision?”
  • “Out of the last seven days, how many were you actually free of it?”
  • “How many weeks has it been every day like this, rather than on and off?”
  • “Of the last seven nights, how many did it wake you or stop you dropping off?”
  • “What’s it like the rest of the year – blocked up first thing when it’s cold too?” – separates a seasonal pattern from a year-round one, which decides how long treatment runs
  • “Tell me about the house – is there a pet, and where does it sleep?”
  • “Did it start over a week or so with a temperature, and did the discharge turn yellow or green?” (sorts a run of colds from allergy)
  • “Does it fire off with cold air, smoke or aftershave rather than pollen – and is there any itch with it?” (irritant rather than allergic)
  • “Any wheeze, tightness or breathlessness running for the ball?” (chest disease behind the night cough)
  • “Can I check a few things I need to rule out – ever one side only, any blood, nosebleeds, facial pain, or change in your smell or vision?”
  • “A lot of people end up going through the family medicine drawer. What have you actually been taking – not what you were given?”
  • “What’s worrying you most about the next three weeks?”

 

PART D – MANAGEMENT SUMMARY

  • Classify first: seven days of seven for seven weeks with five broken nights is persistent and moderate-to-severe – that, not the label, chooses a spray over a tablet.
  • Prescribe mometasone 50 micrograms per spray, two sprays into each nostril once daily through the exposure period, anchored to teeth-brushing; one spray each side when controlled.
  • Counsel the clock, or the plan fails: “You’ll notice something within six to eight hours, but it won’t be at full strength until you’ve been on it about two weeks” – and don’t exceed the dose or switch preparation.
  • Teach technique in the room – look down, opposite hand aiming outwards, breathe in gently, do not sniff – and have him say it back.
  • Stop the borrowed chlorphenamine tonight, with the reason: drowsiness dulls concentration and slows reactions, and he has a driving lesson in four days and exams in three weeks.
  • Advise sodium cromoglicate 2% eye drops from the pharmacy, one or two drops into each eye four times daily from today – two weeks to full effect, no rubbing, no driving until vision clears.
  • Advise pollen avoidance round his week – shower and hair-wash after football, bedroom window shut at peak times, wraparound sunglasses – and trial the cat out of the bedroom; signpost Allergy UK and NHS.UK.
  • Review on video in two weeks, before the exams – no tests needed; if nasal symptoms persist, add an intranasal antihistamine.
  • Safety-net: if vision blurs or changes, stop the spray and ring the same day; ring if mood or temper changes or nosebleeds recur; if symptoms turn one-sided or bloody, be seen.
AT A GLANCE

Duration – intermittent: under four days a week or under four weeks. Persistent: four or more days a week and four or more weeks.

Severity – mild: sleep and daily activities undisturbed. Moderate to severe: either affected.

Choosing – mild and/or intermittent in adolescents and adults: any first-line option. Moderate-to-severe or persistent: a regular intranasal corticosteroid, alone or with an intranasal antihistamine.

Combining – adding an intranasal antihistamine beats the corticosteroid alone; adding an oral one does not.

Timing – onset 6–8 hours; maximal effect two weeks; restart two weeks before the next exposure.

PART E – CASE VARIATIONS

The same problem in an eight-year-old

Changed fact(s): Patient aged eight, a parent talking, symptoms mild and intermittent.

The candidate needs to: measure and record height, ask what corticosteroid the child gets by any other route, ask what has been bought, and take the steroid worry seriously.

Management pivot: mild and/or intermittent in a child gets an antihistamine first – intranasal or oral non-sedating – not a nasal corticosteroid. If one is needed later, use the paediatric dose (mometasone 50 micrograms, one spray into each nostril once daily, ages 3 to 11) and prefer a low-bioavailability preparation, which answers the parent’s worry too. Over-the-counter cough and cold medicines, sedating antihistamines included, should not be used under six; from six to twelve they are pharmacy-only. Record height; refer to a paediatrician if growth slows.

What remains unchanged: the classification, the red-flag screen, the trigger history, the technique and the review – re-confirmed with the parent, not assumed.

Teaching point: in children the first-line choice moves with age as well as severity – and the height you did not measure is the one you cannot compare against later.

Coexisting asthma

Changed fact(s): Toby also has asthma, on an inhaled corticosteroid, and his nose is still bad at the two-week review.

The candidate needs to: check adherence and technique with both devices before adding anything, ask how the asthma has been, and take a mood and sleep baseline now.

Management pivot: where symptoms persist and there is asthma, a leukotriene receptor antagonist may be added to an oral or intranasal antihistamine. Montelukast is licensed for seasonal allergic rhinitis only in people who also have asthma; at fifteen to seventeen and in adults, 10 mg once daily, evening. The MHRA (Medicines and Healthcare products Regulatory Agency) has strengthened the warnings with a black box: be alert for neuropsychiatric reactions at any age – sleep disturbance, nightmares, anxiety, agitation, aggression, rarely hallucinations and suicidal thinking; discontinue if new or worsening symptoms appear; tell family and friends, because he may not notice the change; report on a Yellow Card.

What remains unchanged: the classification, the spray and its counselling, the safety-net and the review – and re-check the spray is genuinely used daily before calling it a failure.

Teaching point: adding a drug decides what you must watch as well as what you prescribe – and here the watching is done by those around him.

 

The injection he saw advertised

Changed fact(s): He opens by asking for “the hay fever injection”, seen advertised online.

The candidate needs to: find out what he thinks it would do and what the advert told him, and whether he has booked or paid.

Management pivot: depot triamcinolone is not recommended for hay fever. An injected preparation cannot be removed if it causes adverse effects, and intramuscular corticosteroids have no role here. Say that plainly, then say what he gets instead, so the answer is a plan, not a refusal. The MHRA and the Committees of Advertising Practice have issued a joint enforcement notice against advertising them – what he saw is advertising, not a recommendation.

What remains unchanged: the classification, the spray, the eye limb, the safety-net and the review – the refusal sits inside that plan.

Teaching point: a request built on an advertisement is answered by explaining what it leaves out, not by dismissing it.

 

PART F – WHY CANDIDATES FAIL THIS CASE

You hear “on and off since it warmed up, some days are worse than others” and you write it down. Now you cannot tell a bad fortnight from seven solid weeks, and every choice after that is a guess dressed as a decision. Ask for the number instead – days free out of the last seven, weeks like this, nights broken out of seven – and let the answer pick the treatment.

You ask “are you on any medication?” and Toby says “No, nothing.” He is telling you the truth; nothing has ever been prescribed for him. So you never find the two of his mother’s Piriton he takes at bedtime, and you leave a drowsy antihistamine running in a learner driver three weeks from an examination hall. Normalise before you ask – the family medicine drawer, what he is actually taking rather than what he was given – and the packet comes off the desk.

You get the diagnosis right, choose the right spray, write it up and move to the close. Nothing you have said protects it from the four-day rule that finished the loratadine, and in a week Toby decides this one “did nothing” too. Say the two numbers out loud: something within six to eight hours, full effect at about two weeks, first exam in three. That is the counselling doing the clinical work.

You hear “it’s only hay fever” and you correct him. He agrees with you, goes quiet, and the thing he actually came in frightened of – sitting down in that hall unable to think, with a conditional offer riding on it – never gets said. Leave the minimising where it is and ask what the lost sleep and the lost revision are costing him. The worry arrives on its own.

You decide you cannot be sure without looking inside his nose, and you spend the back half of the consultation persuading a boy with three weeks of revision left to come to the surgery. Nothing you would see there changes the drug, the dose or the safety-net, and the inside of the nose is often normal in this condition anyway. Finish it on video and spend what you saved on the technique.

 

Important Disclaimer

This MedDigest consultation is a fictional case, created for educational and revision purposes only. It should not be used for clinical decision-making or as a substitute for your own clinical judgment.

This content is an independent educational resource designed by MedDigest to illustrate clinical principles. It has not been produced, reviewed, or endorsed by NICE or the Royal College of General Practitioners.

Medicine is constantly evolving. For definitive recommendations, always refer to the latest official guidelines and your local clinical protocols.

MedDigest and its authors cannot accept responsibility for any loss or injury resulting from the use of the information contained herein.

 

References

Allergy UK (2021) Allergic rhinitis and hay fever. Factsheet, 6 July. Available at: https://www.allergyuk.org (Accessed: 23 August 2026).

Azari, A.A. and Arabi, A. (2020) ‘Conjunctivitis: a systematic review’, Journal of Ophthalmic and Vision Research, 15(3), pp. 372–395. doi:10.18502/jovr.v15i3.7456.

Benacort Hayfever Relief for Adults 64 micrograms nasal spray: summary of product characteristics (2025). Revised 1 October. Available at: https://www.medicines.org.uk/emc/product/12041/smpc (Accessed: 23 August 2026).

Brozek, J.L., Bousquet, J., Agache, I., et al. (2017) ‘Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines – 2016 revision’, Journal of Allergy and Clinical Immunology, 140(4), pp. 950–958. doi:10.1016/j.jaci.2017.03.050.

Haleon UK Trading Limited (2025) Fluticasone propionate 0.05% w/w nasal spray (Flixonase Allergy, Pirinase Hayfever, Pirinase Allergy): summary of product characteristics. PL 44673/0099. Revised 15 December. Available at: https://www.medicines.org.uk/emc/product/4502/smpc (Accessed: 23 August 2026).

Haleon UK Trading Limited (2025) Pirinase Hayfever Once Daily 0.05% nasal spray: summary of product characteristics. PL 44673/0100. Revised 13 January. Available at: https://www.medicines.org.uk/emc/product/5116/smpc (Accessed: 23 August 2026).

Joint Formulary Committee (2026) ‘Antihistamines, allergen immunotherapy and allergic emergencies’, British National Formulary. London: BMJ Group and Pharmaceutical Press. Available at: https://bnf.nice.org.uk (Accessed: 23 August 2026).

Joint Formulary Committee (2026) ‘Azelastine hydrochloride’, British National Formulary. London: BMJ Group and Pharmaceutical Press. Available at: https://bnf.nice.org.uk (Accessed: 23 August 2026).

Joint Formulary Committee (2026) ‘Chlorphenamine maleate’, British National Formulary. London: BMJ Group and Pharmaceutical Press. Available at: https://bnf.nice.org.uk (Accessed: 23 August 2026).

Joint Formulary Committee (2026) ‘Sodium cromoglicate’, British National Formulary. London: BMJ Group and Pharmaceutical Press. Available at: https://bnf.nice.org.uk (Accessed: 23 August 2026).

Joint Formulary Committee (2026) British National Formulary for Children. London: BMJ Group and Pharmaceutical Press. Available at: https://bnfc.nice.org.uk (Accessed: 23 August 2026).

Lipworth, B., Newton, J., Ram, B., Small, I. and Schwarze, J. (2017) ‘An algorithm recommendation for the pharmacological management of allergic rhinitis in the UK: a consensus statement from an expert panel’, npj Primary Care Respiratory Medicine, 27, 3. doi:10.1038/s41533-016-0001-y.

Medicines and Healthcare products Regulatory Agency (2009) ‘Over-the-counter cough and cold medicines for children’, Drug Safety Update, 2(9), p. 8. Available at: https://www.gov.uk/drug-safety-update (Accessed: 23 August 2026).

Medicines and Healthcare products Regulatory Agency (2010) ‘Inhaled and intranasal corticosteroids: risk of psychological and behavioural side effects’, Drug Safety Update, 4(2), A4. Available at: https://www.gov.uk/drug-safety-update (Accessed: 23 August 2026).

Medicines and Healthcare products Regulatory Agency (2017) ‘Corticosteroids: rare risk of central serous chorioretinopathy with local as well as systemic administration’, Drug Safety Update, 15 August. Available at: https://www.gov.uk/drug-safety-update (Accessed: 23 August 2026).

Medicines and Healthcare products Regulatory Agency (2024) ‘Montelukast: reminder of the risk of neuropsychiatric reactions’, Drug Safety Update, 17(9). Available at: https://www.gov.uk/drug-safety-update (Accessed: 23 August 2026).

Medicines and Healthcare products Regulatory Agency (2025) European first as MHRA approves over-the-counter allergy treatment for adolescents aged 12 and over. Press release, 15 December. Available at: https://www.gov.uk/government/news/european-first-as-mhra-approves-over-the-counter-allergy-treatment-for-adolescents-aged-12-and-over (Accessed: 23 August 2026).

NHS (no date) Hay fever. Available at: https://www.nhs.uk/conditions/hay-fever/ (Accessed: 23 August 2026).

Organon Pharma (UK) Limited (2025) Nasonex 50 micrograms/actuation nasal spray, suspension: summary of product characteristics. Revised 2 January. Available at: https://www.medicines.org.uk/emc (Accessed: 23 August 2026).

Ranbaxy (UK) Limited (2024) Loratadine 10 mg tablets: summary of product characteristics. Revised 24 January. Available at: https://www.medicines.org.uk/emc (Accessed: 23 August 2026).

Royal College of General Practitioners (no date) Feedback statements for the SCA. Available at: https://www.rcgp.org.uk/mrcgp-exams/simulated-consultation-assessment/feedback-statements (Accessed: 23 August 2026).

Royal College of General Practitioners (no date) Marking and results for the SCA. Available at: https://www.rcgp.org.uk/mrcgp-exams/simulated-consultation-assessment/marking-and-results (Accessed: 23 August 2026).

Scadding, G.K. et al. (2017) ‘BSACI guideline for the diagnosis and management of allergic and non-allergic rhinitis (revised edition 2017; first edition 2007)’, Clinical and Experimental Allergy, 47(7), pp. 856–889. doi:10.1111/cea.12953.

Strides Pharma UK Ltd (2024) Chlorphenamine 4 mg tablets: summary of product characteristics. Revised 21 October. Available at: https://www.medicines.org.uk/emc (Accessed: 23 August 2026).

Thornton & Ross Ltd (2024) Opticrom Allergy 2% w/v eye drops, solution: summary of product characteristics. Revised 22 March. Available at: https://www.medicines.org.uk/emc (Accessed: 23 August 2026).

Wise, S.K. et al. (2023) ‘International consensus statement on allergy and rhinology: allergic rhinitis – 2023’, International Forum of Allergy and Rhinology, 13(4), pp. 293–859. doi:10.1002/alr.23090.

EXAMPLE CONSULTATION EXCERPTS

Opening note for learner: After you’ve attempted this case, use these excerpts to learn how a passing candidate handles the moments that matter most. Each shows a weaker version and a stronger version of the same moment, so you can hear the difference. The point isn’t to memorise the wording – it’s to recognise the decision being made and learn to make it in your own voice.

How to use these excerpts:

  1. Read both versions aloud.
  2. Name what changed between the weak and strong versions before you read the explanation.
  3. Cover the strong version. Try saying the same moment in your own words.
  4. Use the “Try this yourself” prompt for active practice – ideally with a study partner playing the patient.

 

MOMENT 1 – “None. All seven.”

The setting: Two minutes in. He has told you his hay fever is worse than it has ever been, that his exams start in three weeks, and that he read the same page four times last night.

The decision: Whether to accept his own account of how bad it is, or turn it into counts before you choose a treatment.

What the marking scheme is rewarding: Getting days, weeks and broken nights as numbers – and using the revision line he offered rather than moving past it.

🔻 Borderline handling (what trainees often do)

GP: “And how long’s this been going on?”

Toby: “On and off since it warmed up, I suppose. Some days are worse than others.”

GP: “Is it worse than other years?”

Toby: “Yeah, definitely worse.”

GP: “And is it affecting you much day to day?”

Toby: “It’s annoying. I just need something stronger, really.”

GP: “Okay – let’s see what we can do for you.”

✅ Strong handling (what a passing candidate does)

GP: “You said you read the same page four times last night. What’s it doing to the revision?”

Toby: “I’m just not getting through it. I sit down, an hour goes, and there’s nothing in my head.”

GP: “I want to put some numbers on that, because how often it’s happening is what decides which treatment is right for you. Out of the last seven days, how many were you actually free of it?”

Toby: “None. All seven.”

GP: “And how long has it been every day like that – not on and off, like that?”

Toby: “Seven weeks, near enough.”

GP: “Of the last seven nights, how many did it wake you or stop you dropping off?”

Toby: “Five. Maybe six.”

GP: “So: seven days out of seven, seven weeks, five broken nights in the last week alone. That isn’t a flare-up. That’s the thing I’m going to treat.”

What changed

  • The weak questions can only be answered with adjectives – worse, annoying, some days. The strong ones can only be answered with numbers.
  • The revision line is used as the way in rather than passed over, so the counting arrives as interest rather than as a checklist.
  • The strong version says the pattern back before naming any treatment, so what follows is visibly built out of his own answers.

The transferable principle: When severity decides the treatment, ask for something countable. “How bad is it?” returns an opinion; “how many of the last seven days?” returns data – and the patient hears you build the plan out of what they just told you.

Phrase variants (three different ways to make the same move – choose what fits your voice):

  • “Out of the last seven days, how many were you completely clear of it?”
  • “Help me put a number on it – walk me through this week, night by night.”
  • “How many mornings this week did you wake up already behind?”

Try this yourself: Take a patient who has just told you something is “on and off”. Out loud, ask three questions in a row that can only be answered with a number – days, weeks, nights. Then say the three numbers back in one sentence and stop talking.

Take one or two of these lines at most, and use them in real surgeries until they stop feeling borrowed. A phrase you’ve said fifty times in clinic is your voice; a phrase you read last night is a stock phrase, and the role-player will hear the difference.

 

MOMENT 2 – The family medicine drawer

The setting: Around five minutes. Your checking questions are done. Nothing has ever been prescribed for him, and his record shows no medication at all.

The decision: Whether to ask what he has been prescribed, or to make it easy for him to say what he has actually been taking.

What the marking scheme is rewarding: Normalising the behaviour before you ask about it, then confirming the drug from the packet rather than from the name he says.

🔻 Borderline handling (what trainees often do)

GP: “Are you on any medication at the moment?”

Toby: “No, nothing. Just the ones Mum bought that didn’t work.”

GP: “What were those?”

Toby: “Loratadine. Ten milligrams. I took them four days and stopped.”

GP: “Okay – so nothing at the moment. Any allergies to any medicines?”

Toby: “Not that I’ve ever known of.”

GP: “Right. Let’s talk about what might actually help.”

✅ Strong handling (what a passing candidate does)

GP: “Before we get to treatment, I want to know what’s actually going into you. A lot of people end up going through whatever’s in the family medicine drawer when nothing’s working – what have you been taking, rather than what you’ve been given?”

Toby: (pause) “…Mum’s Piriton. Two of them, at bedtime. Most nights for about ten days. It’s the only thing that gets me to sleep.”

GP: “Thank you for telling me that – it tells me more about your nights than anything else you’ve said. Have you got the box there?”

Toby: (picks it up and holds it to the camera) “Yeah.”

GP: “Read me what it says on it.”

Toby: “Piriton Allergy Tablets. Chlorphenamine maleate, four milligrams.”

GP: “Tablets rather than the syrup – so two of those is eight milligrams a night. That’s worth knowing before I change anything.”

What changed

  • The weak question asks about prescriptions. The strong one asks about behaviour, and makes the behaviour ordinary before asking about it.
  • The weak version takes a name spoken aloud as a medication history. The strong version asks him to read the box, so the drug, the strength and the form are all known.
  • The disclosure is met with thanks and then used, rather than with a change of subject – which is what keeps him talking for the rest of the consultation.

The transferable principle: If a patient might be embarrassed by the true answer, make the behaviour ordinary before you ask for it, and ask what they take rather than what they were given. Then check the product, because a name said out loud is not a drug and a dose.

Phrase variants (three different ways to make the same move – choose what fits your voice):

  • “Most households have a drawer with somebody else’s tablets in it. What have you had out of yours?”
  • “I’m less interested in what’s on your prescription than in what you’ve actually swallowed this week. What’s it been?”
  • “Anything you’ve borrowed, bought, or been handed by someone at home? People usually have.”

Try this yourself: Pick a question you’d normally ask closed – medication, alcohol, smoking, whether they’re actually taking it. Say the normalising sentence first, then the question. Notice how much longer the answer gets.

Take one or two of these lines at most, and use them in real surgeries until they stop feeling borrowed. A phrase you’ve said fifty times in clinic is your voice; a phrase you read last night is a stock phrase, and the role-player will hear the difference.

 

MOMENT 3 – “My offer’s conditional.”

The setting: About seven minutes. He has spent the consultation calling it “just hay fever”, and you are about to offer him a plan.

The decision: Whether to correct the way he’s playing it down, or leave it standing and ask what he is actually frightened of.

What the marking scheme is rewarding: Letting the minimising stand and exploring what it’s costing him, instead of putting him right.

🔻 Borderline handling (what trainees often do)

GP: “I wouldn’t call it ‘just’ hay fever, to be fair – it’s costing you five nights’ sleep a week.”

Toby: “Yeah. I suppose.”

GP: “It’s a proper condition, and it’s very treatable. Let’s not underplay it.”

Toby: “Okay.”

GP: “Anything worrying you about it?”

Toby: “Not really. I just want something that works.”

GP: “Good. So, the plan…”

✅ Strong handling (what a passing candidate does)

GP: “You’ve called it ‘only hay fever’ three times now. You’ve also told me you’ve lost five nights this week and you can’t hold a page. What’s the part of it you’re actually worried about, with three weeks to go?”

Toby: (pause)

GP: (leaves the pause)

Toby: “That I’m going to sit down in that hall and not be able to think. My offer’s conditional.”

GP: “Then that’s what we’re treating. Not the sneezing – being able to think in that hall, and sleeping the nights before it.”

Toby: “Yeah.”

GP: “So everything I’m about to suggest is aimed at that, and I’ll tell you how long each part takes to work.”

What changed

  • The weak version corrects his framing. The strong version quotes it back and sets his own numbers beside it, then asks.
  • The weak worry question is closed and arrives with no space after it. The strong one is open, tied to the three weeks, and is followed by silence rather than by another question.
  • The strong version turns what he says into the aim of the plan, so the treatment that follows is about the exam hall rather than about his nose.

The transferable principle: When a patient plays something down, don’t take the bait and don’t correct it. Say their words back with their own facts beside them, ask one open question about what’s underneath – then leave a gap long enough to be uncomfortable.

Phrase variants (three different ways to make the same move – choose what fits your voice):

  • “You’ve said ‘only hay fever’ a few times. You’ve also told me you’ve lost five nights this week. What’s worrying you most about the next three weeks?”
  • “If this is exactly the same on the morning of your first exam, what happens?”
  • “Can I ask what you’re most afraid of here? Take your time.”

Try this yourself: Find the last consultation where somebody said “it’s nothing really”. Say their phrase back, add one fact they gave you, then ask an open question about what’s underneath – and count three seconds before you speak again.

Take one or two of these lines at most, and use them in real surgeries until they stop feeling borrowed. A phrase you’ve said fifty times in clinic is your voice; a phrase you read last night is a stock phrase, and the role-player will hear the difference.

 

MOMENT 4 – “Everyone gets tablets for hay fever.”

The setting: Late in the consultation. He has the plan, and he asks the question he came in with.

The decision: Whether to hand over the tablets he’s asking for, refuse them flatly, or explain the trade and give him a route back.

What the marking scheme is rewarding: Answering the request as a trade-off with a named next step, using his own experience rather than your authority.

🔻 Borderline handling (what trainees often do)

Toby: “Why can’t you just give me the strongest tablets? Everyone gets tablets for hay fever.”

GP: “Tablets aren’t really the right treatment for a blocked nose – the spray is what works for that. Trust me, it’s the better option.”

Toby: “Right.”

GP: “Give it a proper go and it should settle down.”

Toby: “Okay.”

✅ Strong handling (what a passing candidate does)

Toby: “Why can’t you just give me the strongest tablets? Everyone gets tablets for hay fever.”

GP: “Because for what you’ve described, the strongest tablet isn’t the strongest treatment. Tablets are good at itch and sneezing and poor at a blocked nose – and blocked is what’s keeping you awake.”

Toby: “Right, but the ones Mum got did nothing at all.”

GP: “That’s the point. Four days of exactly that, and it did nothing for the blockage. Putting one on top of the spray wouldn’t change that, so it’d be a second thing to remember for no extra benefit.”

Toby: “So what if the spray doesn’t work either?”

GP: “Then we don’t stop there. If it isn’t enough when I see you in two weeks, the next step is an antihistamine spray alongside it, and that one does add to the first. Two weeks from tomorrow still leaves you a week before your first exam.”

Toby: “Okay, yeah.”

GP: “So it isn’t that you can’t have more. It’s that the spray goes first, and I’ve told you what comes after it if it needs to.”

What changed

  • The weak version leans on authority – “trust me”. The strong version uses his own four days of tablets as the evidence.
  • The weak refusal has no route back, so the answer is simply no. The strong one names what happens if the spray isn’t enough, which turns “no” into “not yet”.
  • The strong version sets the timing against his exam date, so he can see the plan fits inside the three weeks rather than having to take it on faith.

The transferable principle: A refusal a patient can accept has three parts – the reason drawn from their own experience, what they get instead, and what happens if that doesn’t work. Leave out the third and it lands as a bare no.

Phrase variants (three different ways to make the same move – choose what fits your voice):

  • “You’ve already tested tablets for four days. What did they do for the blockage?”
  • “There’s a swap here: tablets act faster and do less, the spray takes longer and does more. For a nose that’s keeping you awake, I’d take the second.”
  • “The spray goes first, and if it’s not enough in two weeks I’ll add to it. You’re not stuck with whatever I give you today.”

Try this yourself: Take a request you’d normally refuse. Say it in three moves – the reason drawn from something the patient has already tried, what you’re offering instead, and what you’ll do if it doesn’t work. Time it: it should take under thirty seconds.

Take one or two of these lines at most, and use them in real surgeries until they stop feeling borrowed. A phrase you’ve said fifty times in clinic is your voice; a phrase you read last night is a stock phrase, and the role-player will hear the difference.

 

MOMENT 5 – “So what do I do tonight?”

The setting: You have just told him to stop taking his mother’s tablets. He asks the obvious question.

The decision: Whether to reassure him that the new treatment will take over, or to plan the gap you have just created.

What the marking scheme is rewarding: Stopping the borrowed tablets and saying what carries the nights until the spray is working.

🔻 Borderline handling (what trainees often do)

Toby: “So what do I do tonight?”

GP: “Just stop them tonight and start the spray in the morning. You’ll notice something within about six to eight hours.”

Toby: “Right, but that’s the only thing getting me to sleep.”

GP: “I know, but it’s not doing you any favours with your driving or your exams. Give the spray a few days and you should notice a difference.”

Toby: “Okay.”

✅ Strong handling (what a passing candidate does)

Toby: “So what do I do tonight?”

GP: “You’re right that it was getting you to sleep. That’s why the plan has to cover the nights as well as the nose.”

Toby: “So what, then?”

GP: “Three things from tonight. Pickle stays out of your bedroom – those first-thing mornings are the ones he’s making worse. And a barrier balm round your nostrils at bedtime, a few pounds from any chemist.”

Toby: “Right.”

GP: “Third one costs nothing. Take the spray in the morning, not last thing, so it’s working through the night rather than starting then.”

Toby: “Okay, yeah.”

GP: “And a marker, so you’re not guessing. By the end of next week the nights should be starting to turn – not fixed, but fewer. Same or worse, ring us before your two-week appointment and we’ll add a spray that works within about fifteen minutes.”

What changed

  • The weak version answers with a timescale. The strong version answers with a plan for the specific nights between now and the spray working.
  • The strong version concedes that the tablets were doing something, so stopping them isn’t a correction of him.
  • The strong version gives a marker he can check himself and a reason to ring early, so the fallback is contact with you rather than quietly restarting the tablets.

The transferable principle: Stopping a medicine creates an interval. Say how long it is, put something in it, and give the patient a marker they can check and a way back to you – otherwise they will fill the gap themselves, with the drug you stopped.

Phrase variants (three different ways to make the same move – choose what fits your voice):

  • “That tablet was doing something for you, so let’s cover the gap it leaves.”
  • “There’s about a fortnight between stopping that and the spray being at full strength. Here’s what carries you across it.”
  • “If the nights aren’t starting to turn by the end of next week, that’s my cue to add something. Ring me rather than going back to the tablets.”

Try this yourself: Take any medicine you’d stop today. Out loud, say how long the gap is, name one thing that fills it, and give one marker the patient can check in a week. Do it in under twenty seconds.

Take one or two of these lines at most, and use them in real surgeries until they stop feeling borrowed. A phrase you’ve said fifty times in clinic is your voice; a phrase you read last night is a stock phrase, and the role-player will hear the difference.

 

MOMENT 6 – Closing on video

The setting: The last minute. The plan is agreed and you are closing the call.

The decision: Whether to recite the whole safety-net, offer to see him in person to be safe, or pick the two things that can’t wait and check he has them.

What the marking scheme is rewarding: Finishing on video with a net he can actually remember, and hearing it back from him.

🔻 Borderline handling (what trainees often do)

GP: “So before you go – if your vision changes, if your mood or temper changes, if you get repeated nosebleeds or your nose stays sore, if your eyes become painful or light bothers you, if you get any wheeze or breathlessness, or if it turns one-sided or there’s blood in it, get in touch. Does that all make sense?”

Toby: “Yeah, fine.”

GP: “And if you’d rather, I could book you in to be seen – just to be on the safe side?”

Toby: “I’ve got three weeks and I’m behind as it is.”

GP: “No problem. Any questions?”

Toby: “No, I’m alright.”

✅ Strong handling (what a passing candidate does)

GP: “Two things I want you to remember without writing them down, because they’re the ones that can’t wait. If your eyes go painful, or light starts bothering you, or your sight changes – that isn’t hay fever, and I want you seen. And if your vision blurs on the spray, ring us the same day.”

Toby: “Okay.”

GP: “Say those two back to me.”

Toby: “Eyes hurting, or light, or my sight – get seen. Vision blurry on the spray – ring the same day.”

GP: “That’s them. Everything else goes to you in writing – the nose list, the chest one and the mood one – so you’re not carrying it in your head three weeks before an exam. Read it once tonight.”

Toby: “Yeah, alright.”

GP: “I’ll see you on video in two weeks, before the exams start, so there’s time to change things. And ring before that if the nights aren’t turning.”

What changed

  • The weak version delivers seven triggers in one breath and checks with a question he can answer without listening. The strong version picks two and asks for them back in his own words.
  • The strong version commits the rest to writing instead of to his memory, and says why.
  • The weak version floats an appointment for reassurance. The strong version closes on video with a named review and a reason to ring sooner, because nothing here needs looking at.

The transferable principle: A safety-net is only as good as what the patient can repeat. Choose the two that can’t wait, ask for them back in their words, and put the rest in writing – and never offer an appointment as a substitute for a plan.

Phrase variants (three different ways to make the same move – choose what fits your voice):

  • “Of everything I’ve said, two things can’t wait. I’ll ask you for them in a minute so I know they’ve landed.”
  • “The full list is coming to you in writing. Out loud, I only want you holding two.”
  • “Before we finish – what would make you ring us before the two weeks are up?”

Try this yourself: Take your usual safety-net for a common presentation. Cut it to the two triggers that can’t wait, and write the sentence that asks the patient to say them back. Practise it until it doesn’t sound like a test.

Take one or two of these lines at most, and use them in real surgeries until they stop feeling borrowed. A phrase you’ve said fifty times in clinic is your voice; a phrase you read last night is a stock phrase, and the role-player will hear the difference.

One-line takeaway for this case: Count before you choose – then spend the rest of the consultation showing him that the plan is made out of his own answers.

Practice plan for this case:

  1. Read through all moments aloud once, just to hear them.
  2. Pick the moment you find hardest. Practise the strong version in your own words five times until it feels natural.
  3. Find a study partner. Have them play the patient. Run the moment without looking at the transcript.
  4. Record yourself. Listen back for the things that change between borderline and strong handling.

 

Important Disclaimer

This MedDigest consultation is a fictional case, created for educational and revision purposes only. It should not be used for clinical decision-making or as a substitute for your own clinical judgment.

This content is an independent educational resource designed by MedDigest to illustrate clinical principles. It has not been produced, reviewed, or endorsed by NICE or the Royal College of General Practitioners.

Medicine is constantly evolving. For definitive recommendations, always refer to the latest official guidelines and your local clinical protocols.

MedDigest and its authors cannot accept responsibility for any loss or injury resulting from the use of the information contained herein.

 

References

Allergy UK (2021) Allergic rhinitis and hay fever. Factsheet, 6 July. Available at: https://www.allergyuk.org (Accessed: 23 August 2026).

Azari, A.A. and Arabi, A. (2020) ‘Conjunctivitis: a systematic review’, Journal of Ophthalmic and Vision Research, 15(3), pp. 372–395. doi:10.18502/jovr.v15i3.7456.

Benacort Hayfever Relief for Adults 64 micrograms nasal spray: summary of product characteristics (2025). Revised 1 October. Available at: https://www.medicines.org.uk/emc/product/12041/smpc (Accessed: 23 August 2026).

Brozek, J.L., Bousquet, J., Agache, I., et al. (2017) ‘Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines – 2016 revision’, Journal of Allergy and Clinical Immunology, 140(4), pp. 950–958. doi:10.1016/j.jaci.2017.03.050.

Haleon UK Trading Limited (2025) Fluticasone propionate 0.05% w/w nasal spray (Flixonase Allergy, Pirinase Hayfever, Pirinase Allergy): summary of product characteristics. PL 44673/0099. Revised 15 December. Available at: https://www.medicines.org.uk/emc/product/4502/smpc (Accessed: 23 August 2026).

Haleon UK Trading Limited (2025) Pirinase Hayfever Once Daily 0.05% nasal spray: summary of product characteristics. PL 44673/0100. Revised 13 January. Available at: https://www.medicines.org.uk/emc/product/5116/smpc (Accessed: 23 August 2026).

Joint Formulary Committee (2026) ‘Antihistamines, allergen immunotherapy and allergic emergencies’, British National Formulary. London: BMJ Group and Pharmaceutical Press. Available at: https://bnf.nice.org.uk (Accessed: 23 August 2026).

Joint Formulary Committee (2026) ‘Azelastine hydrochloride’, British National Formulary. London: BMJ Group and Pharmaceutical Press. Available at: https://bnf.nice.org.uk (Accessed: 23 August 2026).

Joint Formulary Committee (2026) ‘Chlorphenamine maleate’, British National Formulary. London: BMJ Group and Pharmaceutical Press. Available at: https://bnf.nice.org.uk (Accessed: 23 August 2026).

Joint Formulary Committee (2026) ‘Sodium cromoglicate’, British National Formulary. London: BMJ Group and Pharmaceutical Press. Available at: https://bnf.nice.org.uk (Accessed: 23 August 2026).

Joint Formulary Committee (2026) British National Formulary for Children. London: BMJ Group and Pharmaceutical Press. Available at: https://bnfc.nice.org.uk (Accessed: 23 August 2026).

Lipworth, B., Newton, J., Ram, B., Small, I. and Schwarze, J. (2017) ‘An algorithm recommendation for the pharmacological management of allergic rhinitis in the UK: a consensus statement from an expert panel’, npj Primary Care Respiratory Medicine, 27, 3. doi:10.1038/s41533-016-0001-y.

Medicines and Healthcare products Regulatory Agency (2009) ‘Over-the-counter cough and cold medicines for children’, Drug Safety Update, 2(9), p. 8. Available at: https://www.gov.uk/drug-safety-update (Accessed: 23 August 2026).

Medicines and Healthcare products Regulatory Agency (2010) ‘Inhaled and intranasal corticosteroids: risk of psychological and behavioural side effects’, Drug Safety Update, 4(2), A4. Available at: https://www.gov.uk/drug-safety-update (Accessed: 23 August 2026).

Medicines and Healthcare products Regulatory Agency (2017) ‘Corticosteroids: rare risk of central serous chorioretinopathy with local as well as systemic administration’, Drug Safety Update, 15 August. Available at: https://www.gov.uk/drug-safety-update (Accessed: 23 August 2026).

Medicines and Healthcare products Regulatory Agency (2024) ‘Montelukast: reminder of the risk of neuropsychiatric reactions’, Drug Safety Update, 17(9). Available at: https://www.gov.uk/drug-safety-update (Accessed: 23 August 2026).

Medicines and Healthcare products Regulatory Agency (2025) European first as MHRA approves over-the-counter allergy treatment for adolescents aged 12 and over. Press release, 15 December. Available at: https://www.gov.uk/government/news/european-first-as-mhra-approves-over-the-counter-allergy-treatment-for-adolescents-aged-12-and-over (Accessed: 23 August 2026).

NHS (no date) Hay fever. Available at: https://www.nhs.uk/conditions/hay-fever/ (Accessed: 23 August 2026).

Organon Pharma (UK) Limited (2025) Nasonex 50 micrograms/actuation nasal spray, suspension: summary of product characteristics. Revised 2 January. Available at: https://www.medicines.org.uk/emc (Accessed: 23 August 2026).

Ranbaxy (UK) Limited (2024) Loratadine 10 mg tablets: summary of product characteristics. Revised 24 January. Available at: https://www.medicines.org.uk/emc (Accessed: 23 August 2026).

Royal College of General Practitioners (no date) Feedback statements for the SCA. Available at: https://www.rcgp.org.uk/mrcgp-exams/simulated-consultation-assessment/feedback-statements (Accessed: 23 August 2026).

Royal College of General Practitioners (no date) Marking and results for the SCA. Available at: https://www.rcgp.org.uk/mrcgp-exams/simulated-consultation-assessment/marking-and-results (Accessed: 23 August 2026).

Scadding, G.K. et al. (2017) ‘BSACI guideline for the diagnosis and management of allergic and non-allergic rhinitis (revised edition 2017; first edition 2007)’, Clinical and Experimental Allergy, 47(7), pp. 856–889. doi:10.1111/cea.12953.

Strides Pharma UK Ltd (2024) Chlorphenamine 4 mg tablets: summary of product characteristics. Revised 21 October. Available at: https://www.medicines.org.uk/emc (Accessed: 23 August 2026).

Thornton & Ross Ltd (2024) Opticrom Allergy 2% w/v eye drops, solution: summary of product characteristics. Revised 22 March. Available at: https://www.medicines.org.uk/emc (Accessed: 23 August 2026).

Wise, S.K. et al. (2023) ‘International consensus statement on allergy and rhinology: allergic rhinitis – 2023’, International Forum of Allergy and Rhinology, 13(4), pp. 293–859. doi:10.1002/alr.23090.

Simulated Consultation Practice

You need 1 credit to start this station. You have 0 credits available.

Buy Credits

Add Your Heading Text Here

Log In

To keep connected with us please login with your personal info

✎ Add Notes & Highlights

Article Notes & Highlights

Recent 5 Notes and highlights